{"transactions":[{"id":2223000,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":125902,"kind":"person","name":"Ford Brian D.","position":1,"cik":"0001825758","reported_name":"Ford Brian D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-06-23T20:34:07.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Based on conversion of exercise price of C$1.15 into U.S. dollars based on an exchange rate of C$1.00 = US$0.7727 on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options granted on 06/22/2022 under Acasti Pharma Inc.'s Stock Option Plan and become exercisable evenly and on a quarterly basis over 36 months."}],"balance_after":165000,"derivative":{"exercise_price":0.89,"expiration_date":"2032-06-22","underlying":"Class A Common Shares","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0001171843-22-004515","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444192/000117184322004515/ownership.xml","form_type":"4"}},{"id":2510496,"issuer":{"id":7266,"kind":"organization","name":"Grace Therapeutics, Inc.","symbol":"GRCE"},"owners":[{"id":125902,"kind":"person","name":"Ford Brian D.","position":1,"cik":"0001825758","reported_name":"Ford Brian D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-11-16T21:18:39.000Z","date":"2021-11-12","kind":"grant","acquired":true,"shares":287900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Based on conversion of exercise price of C$2.05 into U.S. dollars based on an exchange rate of C$1.00 = US$0.7959 on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options granted on 11/12/2021 under Acasti Pharma Inc.'s Stock Option Plan and become exercisable evenly and on a quarterly basis over 36 months."}],"balance_after":287900,"derivative":{"exercise_price":1.63,"expiration_date":"2031-11-12","underlying":"Class A Common Shares","underlying_shares":287900},"source":{"system":"sec-edgar","filing":"0001171843-21-008007","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444192/000117184321008007/ownership.xml","form_type":"4"}}]}